Pompilio, Giuseppe, Alessandro Morabito, Diego L. Cortinovis, and Davide Integlia. 2022. “Budget Impact Analysis of Afatinib for First-Line Treatment of Non-Small Cell Lung Cancer (NSCLC) Patients With Uncommon EGFR Mutations”. Global and Regional Health Technology Assessment 9 (1):22-29. https://doi.org/10.33393/grhta.2022.2351.